Cargando…

Sirolimus-Eluting Balloon for the Treatment of Coronary Lesions in Complex ACS Patients: The SELFIE Registry

BACKGROUND: Sirolimus-coated balloons (SCBs) represent a novel therapeutic option for both in-stent restenosis (ISR) and de novo coronary lesions treatment, especially in small vessels. Our registry sought to evaluate the procedural and clinical outcomes of such devices in a complex acute coronary s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caiazzo, Gianluca, De Michele, Mario, Golino, Luca, Manganiello, Vincenzo, Fattore, Luciano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586180/ https://www.ncbi.nlm.nih.gov/pubmed/33132769 http://dx.doi.org/10.1155/2020/8865223

Ejemplares similares

Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry
por: Maeng, Michael, et al.
Publicado: (2012)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Sirolimus-eluting coronary stents: a review
por: Abizaid, Alexandre
Publicado: (2007)

Comparison of Sirolimus and Paclitaxel-Eluting Stents for Complex Coronary Lesions: An Intravascular Ultrasound Study
por: Cho, Yun-Kyeong, et al.
Publicado: (2009)

Coronary Computed Tomography Angiography for the Assessment of Sirolimus-Eluting Resorbable Magnesium Scaffold
por: Tonet, Elisabetta, et al.
Publicado: (2022)

Utility of the selution SLR™ sirolimus eluting balloon to rescue failing arterio-venous fistulas – 12 month results of the ISABELLA Registry from Singapore
por: Tang, Tjun Y, et al.
Publicado: (2022)

Early vascular healing of ultra-thin strut polymer-free sirolimus-eluting stents in acute coronary syndrome: USUI-ACS study
por: Matsuhiro, Yutaka, et al.
Publicado: (2022)

Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
por: Thim, Troels, et al.
Publicado: (2012)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

Early-Period Coronary Aneurysm Formation After Sirolimus-Eluting Stent Implantation
por: Kaya, Cihad, et al.
Publicado: (2023)

Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
por: Sharma, Raghav, et al.
Publicado: (2022)

Development of a Coronary Aneurysm at a Sirolimus-Eluting Stent-Implanted Lesion in a Patient With Churg-Strauss Syndrome
por: Cho, Yujung, et al.
Publicado: (2011)

Open-labeled randomized controlled trial to evaluate the 1-year clinical outcomes of polymer-free sirolimus-eluting coronary stents as compared with biodegradable polymer-based sirolimus-eluting coronary stents
por: Viswanathan, Sunitha, et al.
Publicado: (2018)

Drug-Eluting Balloons in the Treatment of Coronary De Novo Lesions: A Comprehensive Review
por: Richelsen, Rasmus Kapalu Broge, et al.
Publicado: (2016)

Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stents: Patient-Level Pooled Analysis From Two Indian Registries
por: Babu Pothineni, Ramesh, et al.
Publicado: (2023)

Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Clinical outcomes of an ultrathin-strut sirolimus-eluting stent in all-comers population: Thailand Orsiro registry
por: Suwannasom, Pannipa, et al.
Publicado: (2021)

A novel biodegradable polymer-coated sirolimus-eluting stent: 1-year results of the HELIOS registry
por: Zheng, Bo, et al.
Publicado: (2023)

Neoatherosclerosis in Sirolimus-Eluting Stents After Paclitaxel-Coated Ballooning Cannot Be Stabilized Despite PCSK9 Inhibitor Therapy
por: Miyoshi, Toru, et al.
Publicado: (2019)

Drug eluting balloons for de novo coronary lesions – a systematic review and meta-analysis
por: Fröhlich, Georg M, et al.
Publicado: (2013)

Clinical Outcomes of Novel Long-Tapered Sirolimus-Eluting Coronary Stent System in Real-World Patients With Long Diffused De Novo Coronary Lesions
por: Patted, Suresh V., et al.
Publicado: (2018)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Efficacy of Sirolimus-Eluting Stents Compared with Paclitaxel-Eluting Stents in an Unselected Population with Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey
por: Çiçek, Davran, et al.
Publicado: (2010)

Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries
por: Sperling, Christian, et al.
Publicado: (2019)

Incidence and natural history of coronary evagination after implanted biodegradable polymer sirolimus-eluting stent
por: Tsuji, Keiko, et al.
Publicado: (2022)

Cutting-balloon angioplasty before drug-eluting stent implantation for the treatment of severely calcified coronary lesions
por: Tang, Zhe, et al.
Publicado: (2014)

Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients
por: Funayama, Naohiro, et al.
Publicado: (2022)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Late Thrombosis of Sirolimus-Eluting Stent: A Multifactorial Problem
por: Kranjec, Igor, et al.
Publicado: (2009)

Long-term effectiveness and safety of sirolimus drug-eluting stents
por: Bikkina, Mahesh, et al.
Publicado: (2011)

A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study
por: Franzone, Anna, et al.
Publicado: (2017)

Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Clinical and Angiographic Outcomes of the First Korean-made Sirolimus-Eluting Coronary Stent with Abluminal Bioresorbable Polymer
por: Yang, Hyoung-Mo, et al.
Publicado: (2017)

Clinical Outcomes from Unselected “Real-World” Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent
por: Polavarapu, Anurag, et al.
Publicado: (2015)

Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
por: Velders, Matthijs A., et al.
Publicado: (2013)

Real-World Experience With a Tapered Biodegradable Polymer-Coated Sirolimus-Eluting Stent in Patients With Long Coronary Artery Stenoses
por: Lupi, Alessandro, et al.
Publicado: (2020)

Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021)

3-Year Clinical Outcomes of Ultrathin Biodegradable Polymer-Coated Sirolimus-Eluting Stents: T-Flex Registry With High-Risk Subgroups
por: Pothineni, Ramesh Babu, et al.
Publicado: (2022)

Drug-eluting balloon: is it useful?
por: Laksono, Sidhi, et al.
Publicado: (2020)

Sirolimus-Eluting Stents vs Uncoated Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery Stenosis
por: Valencia, José, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_c5577nnu2beuk2ca777i88daqo